DRR Guidance Document - ECPA EffEG

The purpose of this study was to assess the effectiveness and safety of tenofovir gel for the prevention of HIV infection in women. Study design and population. CAPRISA 004, a two-arm, double-blind, randomized, placebo-controlled trial, was conducted from May 2007 to March 2010. ................
................